{"id":8231,"date":"2023-02-09T11:41:00","date_gmt":"2023-02-09T10:41:00","guid":{"rendered":"https:\/\/www.institutmacula.com\/?p=8231"},"modified":"2025-12-10T11:59:29","modified_gmt":"2025-12-10T10:59:29","slug":"dmae-atrofica-syfovre-izervay-parasol-terapia-genica","status":"publish","type":"post","link":"https:\/\/www.institutmacula.com\/es\/dmae-atrofica-syfovre-izervay-parasol-terapia-genica\/","title":{"rendered":"F\u00e1rmacos contra la DMAE atr\u00f3fica: estado de la cuesti\u00f3n"},"content":{"rendered":"\n<p class=\"has-ast-global-color-8-color has-text-color has-link-color wp-elements-d45088fedcc046ba476d7dbbd867e3ab\"><a href=\"https:\/\/www.institutmacula.com\/patologia\/dmae-atrofica\/\">La agencia norteamericana del medicamento, la FDA, tiene aprobados hace meses los primeros f\u00e1rmacos para el tratamiento de la atrofia geogr\u00e1fica, la fase avanzada de la DMAE atr\u00f3fica.\u00a0Al ser una patolog\u00eda que hasta el momento en que se aprobaron estos medicamentos no ten\u00eda ning\u00fan tratamiento,\u00a0<strong>Syfovre e Izervay abren una puerta que durante muchos a\u00f1os hab\u00eda estado cerrada. El Institut de la M\u00e0cula ha formado parte de los centros internacionales que han contribuido al desarrollo de estos f\u00e1rmacos y conoce de cerca las ventajas que pueden suponer en algunos de los pacientes, cuya evoluci\u00f3n debe conocerse y seguirse de manera minuciosa<\/strong>.<\/a><\/p>\n\n\n\n<p class=\"has-ast-global-color-8-color has-text-color has-link-color wp-elements-829130ac0b4a2c67e1f0d7ed9943659f\"><a href=\"https:\/\/www.institutmacula.com\/patologia\/dmae-atrofica\/\">Aunque por estas fechas esper\u00e1bamos tener ya la luz verde de la Agencia Europea de Medicamentos, la EMA, para utilizarlos en Europa, el Comit\u00e9 de Medicamentos para Uso Humano,\u00a0<strong>el \u00f3rgano de la Agencia que decide la aprobaci\u00f3n de los f\u00e1rmacos, est\u00e1 bloqueando la autorizaci\u00f3n del Syfovre<\/strong>. Esta situaci\u00f3n no es definitiva, ya que\u00a0<strong>la farmac\u00e9utica responsable del medicamento ha pedido su revisi\u00f3n<\/strong>.<\/a><\/p>\n\n\n\n<p class=\"has-ast-global-color-8-color has-text-color has-link-color wp-elements-beb5d00c261227853ac4cc1043786446\"><a href=\"https:\/\/www.institutmacula.com\/patologia\/dmae-atrofica\/\">Desde el Institut de la M\u00e0cula seguimos de cerca las evoluciones del nuevo f\u00e1rmaco, aplicado ya hace meses de manera extensiva en Estados Unidos, y somos conscientes de que\u00a0<strong>es de importancia extrema conocer con precisi\u00f3n las caracter\u00edsticas particulares de cada paciente<\/strong>. Se convierte en m\u00e1s importante que nunca el an\u00e1lisis de cada caso y la indicaci\u00f3n adecuada, ya que desde las conclusiones mismas de los ensayos cl\u00ednicos sabemos que para algunos pacientes el tratamiento no estar\u00e1 indicado. Del mismo modo,\u00a0<strong>estamos convencidos de que, actuando de forma r\u00e1pida, en los pacientes adecuados se podr\u00eda ralentizar la progresi\u00f3n de la enfermedad<\/strong>.<\/a><\/p>\n\n\n\n<p class=\"has-ast-global-color-8-color has-text-color has-link-color wp-elements-9c88f6cc5ea121464c927eff4021d18e\"><a href=\"https:\/\/www.institutmacula.com\/patologia\/dmae-atrofica\/\">En el Institut de la M\u00e0cula, donde conocemos muy bien los m\u00faltiples subtipos y los pron\u00f3sticos de la patolog\u00eda,<strong>\u00a0somos muy conscientes de que algunos pacientes necesitan el tratamiento lo antes posible\u00a0<\/strong>y, por la evoluci\u00f3n de la patolog\u00eda, no pueden esperar a la resoluci\u00f3n definitiva de la EMA.<strong>\u00a0Por eso estudiamos alternativas para poner el nuevo f\u00e1rmaco a su disposici\u00f3n<\/strong>.<\/a><\/p>\n\n\n\n<p><\/p>\n","protected":false},"excerpt":{"rendered":"<p>La agencia norteamericana del medicamento, la FDA, tiene aprobados hace meses los primeros f\u00e1rmacos para el tratamiento de la atrofia geogr\u00e1fica, la fase avanzada de la DMAE atr\u00f3fica.\u00a0Al ser una patolog\u00eda que hasta el momento en que se aprobaron estos medicamentos no ten\u00eda ning\u00fan tratamiento,\u00a0Syfovre e Izervay abren una puerta que durante muchos a\u00f1os hab\u00eda [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":8232,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"set","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[33],"tags":[],"class_list":["post-8231","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-noticias"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Izervay y Terapia G\u00e9nica para DMAE Atr\u00f3fica | Institut de la M\u00e0cula<\/title>\n<meta name=\"description\" content=\"Conoce el estado de Syfovre e Izervay (FDA) para la DMAE atr\u00f3fica. El Institut de la M\u00e1cula participa en Parasol, ensayo de terapia g\u00e9nica.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.institutmacula.com\/es\/dmae-atrofica-syfovre-izervay-parasol-terapia-genica\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Izervay y Terapia G\u00e9nica para DMAE Atr\u00f3fica | Institut de la M\u00e0cula\" \/>\n<meta property=\"og:description\" content=\"Conoce el estado de Syfovre e Izervay (FDA) para la DMAE atr\u00f3fica. El Institut de la M\u00e1cula participa en Parasol, ensayo de terapia g\u00e9nica.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.institutmacula.com\/es\/dmae-atrofica-syfovre-izervay-parasol-terapia-genica\/\" \/>\n<meta property=\"og:site_name\" content=\"Institut de la M\u00e0cula\" \/>\n<meta property=\"article:published_time\" content=\"2023-02-09T10:41:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-12-10T10:59:29+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.institutmacula.com\/wp-content\/uploads\/2025\/12\/farmacos-contra-la-dmae-scaled.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1707\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"mllibre\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"mllibre\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.institutmacula.com\/es\/dmae-atrofica-syfovre-izervay-parasol-terapia-genica\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.institutmacula.com\/es\/dmae-atrofica-syfovre-izervay-parasol-terapia-genica\/\"},\"author\":{\"name\":\"mllibre\",\"@id\":\"https:\/\/www.institutmacula.com\/es\/#\/schema\/person\/a686371d69fa87f058071b9d5a952536\"},\"headline\":\"F\u00e1rmacos contra la DMAE atr\u00f3fica: estado de la cuesti\u00f3n\",\"datePublished\":\"2023-02-09T10:41:00+00:00\",\"dateModified\":\"2025-12-10T10:59:29+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.institutmacula.com\/es\/dmae-atrofica-syfovre-izervay-parasol-terapia-genica\/\"},\"wordCount\":377,\"publisher\":{\"@id\":\"https:\/\/www.institutmacula.com\/es\/#organization\"},\"image\":{\"@id\":\"https:\/\/www.institutmacula.com\/es\/dmae-atrofica-syfovre-izervay-parasol-terapia-genica\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.institutmacula.com\/wp-content\/uploads\/2025\/12\/farmacos-contra-la-dmae-scaled.jpg\",\"articleSection\":[\"Noticias\"],\"inLanguage\":\"es\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.institutmacula.com\/es\/dmae-atrofica-syfovre-izervay-parasol-terapia-genica\/\",\"url\":\"https:\/\/www.institutmacula.com\/es\/dmae-atrofica-syfovre-izervay-parasol-terapia-genica\/\",\"name\":\"Izervay y Terapia G\u00e9nica para DMAE Atr\u00f3fica | Institut de la M\u00e0cula\",\"isPartOf\":{\"@id\":\"https:\/\/www.institutmacula.com\/es\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.institutmacula.com\/es\/dmae-atrofica-syfovre-izervay-parasol-terapia-genica\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.institutmacula.com\/es\/dmae-atrofica-syfovre-izervay-parasol-terapia-genica\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.institutmacula.com\/wp-content\/uploads\/2025\/12\/farmacos-contra-la-dmae-scaled.jpg\",\"datePublished\":\"2023-02-09T10:41:00+00:00\",\"dateModified\":\"2025-12-10T10:59:29+00:00\",\"description\":\"Conoce el estado de Syfovre e Izervay (FDA) para la DMAE atr\u00f3fica. El Institut de la M\u00e1cula participa en Parasol, ensayo de terapia g\u00e9nica.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.institutmacula.com\/es\/dmae-atrofica-syfovre-izervay-parasol-terapia-genica\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.institutmacula.com\/es\/dmae-atrofica-syfovre-izervay-parasol-terapia-genica\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.institutmacula.com\/es\/dmae-atrofica-syfovre-izervay-parasol-terapia-genica\/#primaryimage\",\"url\":\"https:\/\/www.institutmacula.com\/wp-content\/uploads\/2025\/12\/farmacos-contra-la-dmae-scaled.jpg\",\"contentUrl\":\"https:\/\/www.institutmacula.com\/wp-content\/uploads\/2025\/12\/farmacos-contra-la-dmae-scaled.jpg\",\"width\":2560,\"height\":1707},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.institutmacula.com\/es\/dmae-atrofica-syfovre-izervay-parasol-terapia-genica\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Inici\",\"item\":\"https:\/\/www.institutmacula.com\/es\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"F\u00e1rmacos contra la DMAE atr\u00f3fica: estado de la cuesti\u00f3n\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.institutmacula.com\/es\/#website\",\"url\":\"https:\/\/www.institutmacula.com\/es\/\",\"name\":\"Institut de la M\u00e0cula\",\"description\":\"Innovating Eye Care\",\"publisher\":{\"@id\":\"https:\/\/www.institutmacula.com\/es\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.institutmacula.com\/es\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.institutmacula.com\/es\/#organization\",\"name\":\"Institut de la M\u00e0cula\",\"url\":\"https:\/\/www.institutmacula.com\/es\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.institutmacula.com\/es\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.institutmacula.com\/wp-content\/uploads\/2024\/02\/logo-Institut-de-la-Macula-24.png\",\"contentUrl\":\"https:\/\/www.institutmacula.com\/wp-content\/uploads\/2024\/02\/logo-Institut-de-la-Macula-24.png\",\"width\":300,\"height\":120,\"caption\":\"Institut de la M\u00e0cula\"},\"image\":{\"@id\":\"https:\/\/www.institutmacula.com\/es\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.institutmacula.com\/es\/#\/schema\/person\/a686371d69fa87f058071b9d5a952536\",\"name\":\"mllibre\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Izervay y Terapia G\u00e9nica para DMAE Atr\u00f3fica | Institut de la M\u00e0cula","description":"Conoce el estado de Syfovre e Izervay (FDA) para la DMAE atr\u00f3fica. El Institut de la M\u00e1cula participa en Parasol, ensayo de terapia g\u00e9nica.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.institutmacula.com\/es\/dmae-atrofica-syfovre-izervay-parasol-terapia-genica\/","og_locale":"es_ES","og_type":"article","og_title":"Izervay y Terapia G\u00e9nica para DMAE Atr\u00f3fica | Institut de la M\u00e0cula","og_description":"Conoce el estado de Syfovre e Izervay (FDA) para la DMAE atr\u00f3fica. El Institut de la M\u00e1cula participa en Parasol, ensayo de terapia g\u00e9nica.","og_url":"https:\/\/www.institutmacula.com\/es\/dmae-atrofica-syfovre-izervay-parasol-terapia-genica\/","og_site_name":"Institut de la M\u00e0cula","article_published_time":"2023-02-09T10:41:00+00:00","article_modified_time":"2025-12-10T10:59:29+00:00","og_image":[{"width":2560,"height":1707,"url":"https:\/\/www.institutmacula.com\/wp-content\/uploads\/2025\/12\/farmacos-contra-la-dmae-scaled.jpg","type":"image\/jpeg"}],"author":"mllibre","twitter_card":"summary_large_image","twitter_misc":{"Escrito por":"mllibre","Tiempo de lectura":"2 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.institutmacula.com\/es\/dmae-atrofica-syfovre-izervay-parasol-terapia-genica\/#article","isPartOf":{"@id":"https:\/\/www.institutmacula.com\/es\/dmae-atrofica-syfovre-izervay-parasol-terapia-genica\/"},"author":{"name":"mllibre","@id":"https:\/\/www.institutmacula.com\/es\/#\/schema\/person\/a686371d69fa87f058071b9d5a952536"},"headline":"F\u00e1rmacos contra la DMAE atr\u00f3fica: estado de la cuesti\u00f3n","datePublished":"2023-02-09T10:41:00+00:00","dateModified":"2025-12-10T10:59:29+00:00","mainEntityOfPage":{"@id":"https:\/\/www.institutmacula.com\/es\/dmae-atrofica-syfovre-izervay-parasol-terapia-genica\/"},"wordCount":377,"publisher":{"@id":"https:\/\/www.institutmacula.com\/es\/#organization"},"image":{"@id":"https:\/\/www.institutmacula.com\/es\/dmae-atrofica-syfovre-izervay-parasol-terapia-genica\/#primaryimage"},"thumbnailUrl":"https:\/\/www.institutmacula.com\/wp-content\/uploads\/2025\/12\/farmacos-contra-la-dmae-scaled.jpg","articleSection":["Noticias"],"inLanguage":"es"},{"@type":"WebPage","@id":"https:\/\/www.institutmacula.com\/es\/dmae-atrofica-syfovre-izervay-parasol-terapia-genica\/","url":"https:\/\/www.institutmacula.com\/es\/dmae-atrofica-syfovre-izervay-parasol-terapia-genica\/","name":"Izervay y Terapia G\u00e9nica para DMAE Atr\u00f3fica | Institut de la M\u00e0cula","isPartOf":{"@id":"https:\/\/www.institutmacula.com\/es\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.institutmacula.com\/es\/dmae-atrofica-syfovre-izervay-parasol-terapia-genica\/#primaryimage"},"image":{"@id":"https:\/\/www.institutmacula.com\/es\/dmae-atrofica-syfovre-izervay-parasol-terapia-genica\/#primaryimage"},"thumbnailUrl":"https:\/\/www.institutmacula.com\/wp-content\/uploads\/2025\/12\/farmacos-contra-la-dmae-scaled.jpg","datePublished":"2023-02-09T10:41:00+00:00","dateModified":"2025-12-10T10:59:29+00:00","description":"Conoce el estado de Syfovre e Izervay (FDA) para la DMAE atr\u00f3fica. El Institut de la M\u00e1cula participa en Parasol, ensayo de terapia g\u00e9nica.","breadcrumb":{"@id":"https:\/\/www.institutmacula.com\/es\/dmae-atrofica-syfovre-izervay-parasol-terapia-genica\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.institutmacula.com\/es\/dmae-atrofica-syfovre-izervay-parasol-terapia-genica\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.institutmacula.com\/es\/dmae-atrofica-syfovre-izervay-parasol-terapia-genica\/#primaryimage","url":"https:\/\/www.institutmacula.com\/wp-content\/uploads\/2025\/12\/farmacos-contra-la-dmae-scaled.jpg","contentUrl":"https:\/\/www.institutmacula.com\/wp-content\/uploads\/2025\/12\/farmacos-contra-la-dmae-scaled.jpg","width":2560,"height":1707},{"@type":"BreadcrumbList","@id":"https:\/\/www.institutmacula.com\/es\/dmae-atrofica-syfovre-izervay-parasol-terapia-genica\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Inici","item":"https:\/\/www.institutmacula.com\/es\/"},{"@type":"ListItem","position":2,"name":"F\u00e1rmacos contra la DMAE atr\u00f3fica: estado de la cuesti\u00f3n"}]},{"@type":"WebSite","@id":"https:\/\/www.institutmacula.com\/es\/#website","url":"https:\/\/www.institutmacula.com\/es\/","name":"Institut de la M\u00e0cula","description":"Innovating Eye Care","publisher":{"@id":"https:\/\/www.institutmacula.com\/es\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.institutmacula.com\/es\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/www.institutmacula.com\/es\/#organization","name":"Institut de la M\u00e0cula","url":"https:\/\/www.institutmacula.com\/es\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.institutmacula.com\/es\/#\/schema\/logo\/image\/","url":"https:\/\/www.institutmacula.com\/wp-content\/uploads\/2024\/02\/logo-Institut-de-la-Macula-24.png","contentUrl":"https:\/\/www.institutmacula.com\/wp-content\/uploads\/2024\/02\/logo-Institut-de-la-Macula-24.png","width":300,"height":120,"caption":"Institut de la M\u00e0cula"},"image":{"@id":"https:\/\/www.institutmacula.com\/es\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/www.institutmacula.com\/es\/#\/schema\/person\/a686371d69fa87f058071b9d5a952536","name":"mllibre"}]}},"_links":{"self":[{"href":"https:\/\/www.institutmacula.com\/es\/wp-json\/wp\/v2\/posts\/8231","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.institutmacula.com\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.institutmacula.com\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.institutmacula.com\/es\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.institutmacula.com\/es\/wp-json\/wp\/v2\/comments?post=8231"}],"version-history":[{"count":1,"href":"https:\/\/www.institutmacula.com\/es\/wp-json\/wp\/v2\/posts\/8231\/revisions"}],"predecessor-version":[{"id":8235,"href":"https:\/\/www.institutmacula.com\/es\/wp-json\/wp\/v2\/posts\/8231\/revisions\/8235"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.institutmacula.com\/es\/wp-json\/wp\/v2\/media\/8232"}],"wp:attachment":[{"href":"https:\/\/www.institutmacula.com\/es\/wp-json\/wp\/v2\/media?parent=8231"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.institutmacula.com\/es\/wp-json\/wp\/v2\/categories?post=8231"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.institutmacula.com\/es\/wp-json\/wp\/v2\/tags?post=8231"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}